|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
0.650 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 199,487 | 46,493 | 665,293 | 227,131 |
| Net Cash from / (used in) Investing Activities | -- | 169,877 | (1,661,121) | (337,569) | (924,777) |
| Net Cash from / (used in) Financing Activities | -- | (419,561) | (238,934) | 750,660 | 184,544 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (50,197) | (1,853,562) | 1,078,384 | (513,102) |
| Cash & Cash Equivalents at beginning of period | -- | 3,828,863 | 5,682,425 | 4,604,041 | 5,117,143 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 0 | 0 | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 3,778,666 | 3,828,863 | 5,682,425 | 4,604,041 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -33,424,000 |
| %Change | -32.673% |
| EPS / (LPS) | RMB -0.004 |
| NBV Per Share (¥) | RMB 0.474 |